Vetter, a pharmaceutical service provider for the production of injectable drugs, has announced plans to build a new production facility in the Saarland region of southwest Germany, marking a significant milestone in the company’s long-term global growth strategy. Construction is scheduled to begin in the second quarter of 2026. Initially, approximately €480 million have been allocated for the first construction phase of the new commercial production plant. The European Commission has approve...